G24S (p.Gly24Ser) variant of KRT4 (Keratin, type II cytoskeletal 4)

G24S (p.Gly24Ser) in KRT4 (Keratin, type II cytoskeletal 4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely benign in the context of Inborn genetic diseases. The available variant effect predictions contribute to a CATVariant prioritization score of 0.36 / 1. The record also includes population frequency data, published literature, and structural context.

G24S (p.Gly24Ser) variant details